Valeo Health ME Secures $12M Series B to Boost Gulf Expansion

Editorial Team

Last updated 27-03-2025

2 min

Valeo Health ME secures $12 million in Series B funding led by Flintera.

The UAE-based startup's total funding now reaches $20 million.

Valeo uses AI to create personalised health plans, catering to growing wellness demands.

Plans include expanding into Saudi Arabia, UAE, and the wider Gulf region.

Founded in 2021, the company aims to innovate further and meet patient needs effectively.

Valeo Health ME, a UAE-based health-tech startup, has just wrapped up a tidy Series B funding round worth $12 million, continuing a streak of fast-paced expansion since its inception barely two years ago.

Leading this latest round of investment was Flintera, with notable participation from other well-known investors such as Nuwa Capital, FJ Labs, Oryx Fund, Mindshift Capital, Oraseya Capital, and Eirad. This cash injection takes the total funding Valeo Health ME has attracted since its establishment to a solid $20 million—not bad going at all for such a young firm.

Valeo Health ME offers personalised healthcare treatments and wellness plans, leveraging cutting-edge artificial intelligence to tailor solutions specifically to individual user needs. Quite a nifty little idea, particularly in an era where we're all feeling increasingly aware of our wellbeing. From daily yoga enthusiasts at my local gym to those friends forever reminding us about the latest Arageek health blogs, our focus on personalised health care feels only set to grow stronger.

With this recent funding boost, Valeo’s plans to broaden its reach are ambitious but practical. Top of the list is an aggressive push to expand in Saudi Arabia, the UAE and across the wider Gulf region, reflecting significant market appetite for digital-first, personalised wellness services.

Founded in 2021 by entrepreneurs Sundeep S., Nadin Karadag and Ankur Majumder, the UAE startup has seen impressive growth in a relatively short spacce of time. They clearly aren’t slowing down anytime soon, with plans to use this new funding to further innovate their platform and roll out enhanced solutions that tackle individual patient requirements head-on.

Given the pace Valeo is moving at—and its knack for bringing personalised care to people's fingertips—it seems likely we'll be hearing much more from them in the months and years ahead.

🚀 Got exciting news to share?

If you're a startup founder, VC, or PR agency with big updates—funding rounds, product launches 📢, or company milestones 🎉 — AraGeek English wants to hear from you!